A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients
Titel:
A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients
Auteur:
Flume, Patrick A. VanDevanter, Donald R. Morgan, Elizabeth E. Dudley, Michael N. Loutit, Jeffery S. Bell, Scott C. Kerem, Eitan Fischer, Rainald Smyth, Alan R. Aaron, Shawn D. Conrad, Douglas Geller, David E. Elborn, J. Stuart